PMID: 8610118Apr 2, 1996Paper

Apoptosis of hemopoietic cells by the human granulocyte-macrophage colony-stimulating factor mutant E21R

Proceedings of the National Academy of Sciences of the United States of America
P O IversenA F Lopez

Abstract

Human granulocyte-macrophage colony-stimulating factor (GM-CSF) binds to a high-affinity heterodimeric receptor composed of a specific alpha chain and a common beta chain (beta(c)), which is shared with the receptors for interleukins 3 and 5. Hemopoietic cell survival requires GM-CSF binding this high-affinity receptor. We have recently developed the GM-CSF mutant E21R, which selectively binds to the alpha chain and behaves as a competitive GM-CSF antagonist. We have now examined the role of E21R on the survival of hemopoietic cells and found that E21R causes apoptosis (programmed cell death) of normal and malignant cells directly in the absence of GM-CSF. The direct apoptotic effect of E21R occurred in a dose- and time-dependent manner. Apoptosis by E21R was dependent on cells expressing the high-affinity GM-CSF receptor and could be blocked by GM-CSF. Significantly, apoptosis of the cells occurred even in the presence of the survival factors granulocyte CSF and stem cell factor but was prevented by engagement of beta(c) with interleukin 3. The initiation of apoptosis required phosphorylation, transcriptional activity, and protein synthesis. These findings support a model whereby binding of E21R to the alpha chain leads to apo...Continue Reading

References

Dec 1, 1992·Immunology Today·A F LopezM A Vadas
Jan 1, 1992·Growth Factors·M J ElliottA F Lopez
Jul 1, 1989·British Journal of Haematology·I A ReillyN H Russell
Sep 1, 1995·The Journal of Experimental Medicine·Q TianP Anderson
Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·T R HercusA F Lopez
Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·P LockN A Nicola

❮ Previous
Next ❯

Citations

Jul 10, 1998·Veterinary Immunology and Immunopathology·K KedzierskaS M Crowe
Dec 31, 1997·American Journal of Respiratory and Critical Care Medicine·P O IversenA F Lopez
Jan 9, 1998·Baillière's Clinical Haematology·J M WoodcockA F Lopez
Feb 8, 2011·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Emil KostovskiPer O Iversen
Nov 26, 2002·Hematology·Robert J ArceciPeter D Emanuel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis